ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,785, issued on Jan. 20, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.).
"MDM2 degraders and uses thereof" was invented by Nan Ji (Arlington, Mass.), Matthew M. Weiss (Boston), Xiaozhang Zheng (Lexington, Mass.) and Xiao Zhu (Winchester, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention."
The patent was filed on March 19, 2021, under Application No. 17/912,416.
*For further information, including images, charts and tabl...